Professional Documents
Culture Documents
Age at onset (code) Age at Onset Disease Duration Nephritic Nephrotic RPGN presentation baseline Chronicity Activity Endocapillary Neutrophilic chronic APS nephropathy thrombotic Leukopenia &/or Thrombo- lupus Anti β 2 Anti β 2
c Name Recorded by Gender [1] Age (years) N at presentation [3] time 2 nephritis (months) [4] hypertension [5] Sterile Pyuria Hematuria Casts SLEDAI 0 Biopsy accurate grade Biopsy Grade Segmental Global Fibrinoid necrosis wire loops hyaline thrombi cellular crescent fibrocellular crescents fibrous crescents interstitial fibrosis glomerular sclerosis tubular atrophy vasculitis lupus vasculopathy 1st Induction [7] Need for sequential induction [8] partial remission [9] complete remission [10] maintainance [11] time to next renal flare [12] No of renal flares No of extrarenal flares CKD ESRD Constitutional MC Serositis Neurological Arthritis Hematologic Hemolytic anemia APS Arterial Venous Comorbidities ANA Anti-DNA Hypocomplementinemia aPL ACL IgG ACL IgM Anti Smith Mortality cause of death seizure (8) psychosis (8) organic brain S (8) visual disturbance (8) cranial nerve disorders (8) lupus headache (8) CVA (8) vasculitis (8) arthritis (4) myositis (4) urinary cast (4) haematuria (4) proteinuria(4) pyuria (4) new rash (2) alopecia (2) mucosal ulcers (2) pleurisy (2) pericarditis (2) low complement (2) increased DNA binding (2) fever (1) low platlet (1) low WBC (1)
[2] (years) (years) presentation presentation presenation creatine >=1.4 Index Index hypercellularity infiltration microangiopathy lymphopenia cytopenia Anticoag. GP 1 IgG GP 1 IgM
TO 16 [6] acute APS nephropathy thrombotic microangiopathy Fibrous intimal hyperplasia fibrous arterial or arterioral occlusion SLEDAI at last visit (score) SLEDAI (grade) any cataract (0,1) retinal or optic atrophy (0,1) cognitive impairement (0,1) seizure (0,1) C.V.A(0,1,2) cranial or peripheral neuropathy (0,1) transeverse myelitis (0,1) GFR<50 (0,1) proteinuria <3.5/24 h (0,1) ESRD (3) PHTN (0,1) Pulm fibrosis (0,1) shrinking lung (0,1) pleural fibrosis (0,1) Pulm infarction (0,1) angina (0,1) myocardial infarction (0,1,2) cardiomyopathy(0,1) valvular ds (0,1) pericarditis (0,1) diabetes (0,1) claudication (0,1) PAD leading to minor tissue loss (0,1) PAD leading to significant tissue Venous
loss (0,1)
thrombosis with swelling, stasis or ulceration (0,1) GIT infarction (0,1,2) mesenteric insufficiency (0,1) chronic peritonitis (0,1) premature gonadal failure(0,1) muscle weakness/atrophy (0,1) deforming or erosive arthritis (0,1) osteoprosis with fracture or vertebral collapse (0,1) A.V.N (0,1,2) osteomyelitis (0,1) scarring chronic alopecia (0,1) extensive scarring of panniculum (0,1) skin ulceration (0,1) malignancy (0,1, 2) SDI score at last visit
1 1 0 0 0 1
اﺑﺘﺴﺎم ﺟﻤﻌﺔ 2 32 2 23 9 0 0 0 0 0 4 5 II-V II-V - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 2 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 1 0 1 0 0 1
2 1 0 0 0 1
اﺑﺘﺴﺎم ﻋﺒﺪ ﷲ 2 36 2 32 5 0 60 0 0 1 0 0 12 3 III III 2 1 0 0 0 0 0 0 0 1 1 1 0 0 1 1 0 2 0 0 1 1 0 1 0 0 0 1 1 1 1 0 1 0 1 1 1 1 1 1 0 11 2
3 1 0 1 1
اﺑﺘﺴﺎم ﻋﺒﺪ اﻟﻨﺒﻲ 2 24 2 17 9 0 0 0 1 1 12 4 IV IV 4 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 1 24 3 4 0 1 1 1 1 0 0 0 0 0 0 0 0 1 1 1 1 0 20 2
4 اﺣﻣد ﻋﻠﻰ 1 56 2 46 10 1 0 0 1 1 0 3 3sA 0 0 0 0 0 1 0 1 0 0 0 0 1 1 0 0 16 1
10 1
اﻣﻞ رﺑﯿﻊ 2 38 8 1 1 1 0 2 II II - 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 0 1 1 1 17 1 1
11 1
اﻣﯿﻨﺔ ﺟﻮدة 2 23 9 1 1 1 0 4 IV IV 2 1 0 0 0 0 0 0 1 1 1 1 1 1 1 0 1 0 1 1 0 1 0 1 1 23 0 0 0 6
During Valve replacement
13 اﯾﻣﺎن ﺷﻌﺑﺎن ﻋﺑد اﻟداﺋم 2 23 2 18 5 0 1 0 1 1 1 5 4s - 5 A 0 0 0 0 0 1 1 0 1 0 1 1 0 0 0 1 1 1 1 0 0 0 0 1 10 0
surgery for RHD
69 0 0 0 1
ﻣﺤﻤﺪ ﻋﺒﺪ اﻟﺒﺎري 1 36 2 22 14 1 0 1 0 0 4 4 IV 1 0 IV 2 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 1 1 0 2 0 0 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 1 1 1 0 12 1
4 s A/C, 3 s A/C +
70 ﻣﺣﻣد ﻋﺑد اﻟرﺣﻣن اﻣﺎم 1 31 2 22 9 0 0 1 1 1 4 1 0 1 1 1 0 0 1 0 1 1 0 0 0 1 0 0 1 0 0 1 1 1 Septic shock 8 3
crescents
72 1
ﻣﺮﻓﺖ ؟ ﻋﺒﺪ اﻟﻌﺰﯾﺰ 2 25 9 0 0 0 0 5 V V - 1 0 0 0 0 0 0 0 0 0 1 1 0 1 1 0 0 0 0 0 1 1 1 11 2
73 0 0 1 1
ﻣﺮﻓﺖ ﺟﻤﺎل 2 26 2 26 60 1 0 1 1 4 3 III III 2 1 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 2 0 0 1 1 0 0 0 0 1 0 1 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 0 0 20 2
74 1 0 0 1
ﻣﺮوة رﺑﯿﻊ 2 15 1 12 3.5 0 24 0 0 1 1 1 4 IV IV 2 1 0 0 0 0 0 0 0 1 0 0 0 0 0 2 1 1 0 2 0 2 1 0 1 1 0 0 1 1 1 1 0 0 0 0 1 1 1 0 0 22 1
75 0 1 1 1
ﻣﻨﻰ ﺣﻨﻔﻲ 2 30 2 25 6 1 0 1 1 1 12 3 II-III II-III 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 1 1 1 2 0 0 1 1 0 0 0 0 0 0 1 0 1 1 0 0 1 0 0 0 1 1 1 0 0 1 1 0 20 0
76 1
ﻣﻨﻰ ﻣﺤﻤﺪ ﻋﺒﺪ اﻟﻤﻨﻌﻢ 2 24 5 1 0 0 1 4 IV IV 4 1 0 0 1 0 0 0 1 0 1 1 0 0 0 0 1 0 1 0 0 0 1 1 1 15 2
77 1
ﻣﯿﺎدة ﻛﺎرم 2 17 2 0 1 0 0 3 III III 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 23 3
78 ﻧﺎدﯾﺔ اﺑراھﯾم ﻋزوز 2 30 2 26 5 1 0 1 0 0 0 1 1 1 0 3 3sC 0 0 0 3 0 0 1 1 0 0 0 0 1 1 0 0 0 1 1 1 1 0 0 0 1 1 1 0 0 0 0 0 0 4 1
0 0 0 0 0 0 0 0 1 0 0 0 0 0
79 ﻧﺎدﯾﺔ ﻋﺑد اﻟﻠطﯾف ﻣﺣﻣد 2 49 2 45 4 0 48 1 0 0 1 1 1 0 1 12 3 3 s A/C 0 0 0 2 0 0 1 1 0 1 1 0 1 1 1 0 1 0 1 1 0 0 0 1 1 1 0 6 0
1 0 0 1 1 0 0 0 0 0 0 0 0 0
82 ﻧﺎھد ﻋﺑد اﻟﻧﺑﻰ ﻣرﺳﻰ 2 36 2 36 1 1 0 1 0 0 1 0 1 1 1 16 2 2 0 0 0 3 0 0 1 1 0 0 0 0 1 1 1 0 1 0 0 0 0 0 0 0 1 1 1 1 0 0 0
1 0 0 0 0 0 0 0 0 0 0 0 0 0
84 ﻧﺠﻮى ﻣﺤﻤﺪ 2 34 2 33 1 0 1 0 1 1 1 0 16 4 IV IV 6 1 0 0 1 1 1 0 1 1 1 0 0 0 1 1 0 2 1 0 0 0 2 1 0 1 1 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 20 2
85 ﻧﻌﻣﺔ ﻣﺣﻣد ﺣﺎﻣد 2 34 2 28 6 0 1 0 0 0 1 0 0 12 3 2-3sC 1 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 2 1 1 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 6 2
4 G A/C +
89 ﻧﻔﯾﺳﺔ ﺣﺳن اﺣﻣد 2 34 2 30 4 0 1 0 1 1 1 1 0 4 4 0 1 6/12 14/24 1 1 1 1 1 0 1 0 1 1 1 1 0 1 0 0 0 2 1 1 1 1 0 1 1 1 1 0 0 0 0 1 1 1 1 0 0 0 0 4 2
Vasculitis
92 ﻧﯾرﻣﯾن ﻣﺣﻣد اﻟطﯾب 2 23 2 17 6 0 1 0 0 0 0 0 0 4 4 4GA 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 2 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 1 0 0 0 4 0
[2] lenovo:
Juvenile onset=1
Adult onset=2
[3] lenovo:
if onset of N can't be known from sheet leave space empty plz
[4] lenovo:
time in months till development of nephritis
if can't be detected leave space empty
if coincided with onset write zero
[5] 0 absent
1 present
[7] lenovo:
MMF:1
CYC:2
AZA:3
[8] lenovo:
Yes: 1
No:0
Need of switch due to lack of response
[9] lenovo:
defined as ≥50% reduction in proteinuria to subnephrotic levels and normal or near-normal GFR
[10] lenovo:
protienuria < 0.5 g/d, and normal or near-normal (within 10% of normal GFR if previously abnormal) GFR
[11] lenovo:
1: AZA
2: MMF
[12] lenovo:
time in months till developed renal flare